Remdesivir production increased to 119 lakh vials per month
Number of approved manufacturing sites of Remdesivir in the country has increased from 22 sites to 60
Number of approved manufacturing sites of Remdesivir in the country has increased from 22 sites to 60
Emoltene 100 Pro will be available in two grades, with different levels of renewable content based on mass balance
DeFu is the third-ranked copper laminate manufacturer in China based on production capacity
CCfDs are a funding mechanism that offer governments the opportunity to guarantee investors a fixed price that rewards CO2 emission reductions
LG Chem will begin finding and fostering domestic companies in the battery materials and eco-friendly materials sectors by participating as a core investor in the prospective ESG company incubation fund
Company is setting up a new supply chain to sell high value-added ingredients to cosmetics sector players from 2022
The investment will expand capacity to support growing demand for advanced mobility solutions for vehicle electrification
The first phase of expansion will be completed by the end of 2021 and the second phase will commercialize in the latter half of 2022
The company has posted net profit of Rs.6.82 crores for the period ended March 31, 2020.
The company has posted net loss of Rs. 99.54 crores for the period ended March 31, 2020
In view of this there could be a potential delay in restart of ammonia and urea plants.
GACL has posted net profit of Rs.165.74 crores for the 12 months period ended March 31, 2021
The company has posted net profit of Rs.696.95 crores for the 12 months period ended March 31, 2021
Natco has withdrawn its application filed with the Indian Patent Office, seeking Compulsory License against Lilly for Baricitinib for Covid-19 in India
Targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses from the date of start of commercial production
The outlook for the US business remains good as respiratory pipeline (gAbraxane, gAdvair, gDulera) adds medium-term growth visibility.
Dr. Reddy's has the rights to distribute 250mn doses in India
India sales grew 23.5% YoY with consolidation of Wockhardt products
Textile chemicals and animal health and nutrition (AHN) bounced back with growth of 30% and 41% YoY
Recognition for service innovation to enhance customer experience
Subscribe to our newsletter & stay updated.